Cargando…

Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer

Estrogen Receptor alpha (ERα) activation by estrogenic hormones induces luminal breast cancer cell proliferation. However, ERα plays also important hormone-independent functions to maintain breast tumor cells epithelial phenotype. We reported previously by RNA-Seq that in MCF-7 cells in absence of h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miano, Valentina, Ferrero, Giulio, Reineri, Stefania, Caizzi, Livia, Annaratone, Laura, Ricci, Laura, Cutrupi, Santina, Castellano, Isabella, Cordero, Francesca, De Bortoli, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823100/ https://www.ncbi.nlm.nih.gov/pubmed/26621851 http://dx.doi.org/10.18632/oncotarget.6420

Ejemplares similares

A Novel Functional Domain of Tab2 Involved in the Interaction with Estrogen Receptor Alpha in Breast Cancer Cells
por: Reineri, Stefania, et al.
Publicado: (2016)

A Regulatory Axis between Epithelial Splicing Regulatory Proteins and Estrogen Receptor α Modulates the Alternative Transcriptome of Luminal Breast Cancer
por: Elhasnaoui, Jamal, et al.
Publicado: (2022)

Luminal breast cancer-specific circular RNAs uncovered by a novel tool for data analysis
por: Coscujuela Tarrero, Lucia, et al.
Publicado: (2018)

The Estrogen Receptor α Signaling Pathway Controls Alternative Splicing in the Absence of Ligands in Breast Cancer Cells
por: Elhasnaoui, Jamal, et al.
Publicado: (2021)

E2 Regulates Epigenetic Signature on Neuroglobin Enhancer-Promoter in Neuronal Cells
por: Guglielmotto, Michela, et al.
Publicado: (2016)

Luminal lncRNAs Regulation by ERα-Controlled Enhancers in a Ligand-Independent Manner in Breast Cancer Cells
por: Miano, Valentina, et al.
Publicado: (2018)

The role of Transposable Elements in shaping the combinatorial interaction of Transcription Factors
por: Testori, Alessandro, et al.
Publicado: (2012)

DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3′-End Usage
por: Elhasnaoui, Jamal, et al.
Publicado: (2020)

Dissecting the genomic activity of a transcriptional regulator by the integrative analysis of omics data
por: Ferrero, Giulio, et al.
Publicado: (2017)

The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
por: Maglione, Alessandro, et al.
Publicado: (2019)

Prolactin-Induced Protein (PIP) Regulates Proliferation of Luminal A Type Breast Cancer Cells in an Estrogen-Independent Manner
por: Baniwal, Sanjeev K., et al.
Publicado: (2013)

Estrogen response in luminal breast cancer
por: Rangel, Leticia B. A., et al.
Publicado: (2013)

Estrogen Receptor-Alpha and p53 Status as Regulators of AMPK and mTOR in Luminal Breast Cancer
por: Gandhi, Nishant, et al.
Publicado: (2021)

Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling
por: Annaratone, Laura, et al.
Publicado: (2013)

Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation
por: Conger, Adrienne K., et al.
Publicado: (2016)

Docker4Circ: A Framework for the Reproducible Characterization of circRNAs from RNA-Seq Data
por: Ferrero, Giulio, et al.
Publicado: (2019)

Membrane estrogen receptor alpha (ERα) participates in flow-mediated dilation in a ligand-independent manner
por: Favre, Julie, et al.
Publicado: (2021)

Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer
por: Pérez-Salvia, Montserrat, et al.
Publicado: (2017)

Arrabidaea chica chloroform extract modulates estrogen and androgen receptors on luminal breast cancer cells
por: Brandão, Douglas C., et al.
Publicado: (2022)

Tamoxifen Treatment of Breast Cancer Cells: Impact on Hedgehog/GLI1 Signaling
por: Villegas, Victoria E., et al.
Publicado: (2016)

AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors
por: Rangel, Nelson, et al.
Publicado: (2020)

Estrogen action at endometrial membranes: alterations in luminal surface detectable within seconds
Publicado: (1983)

STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas
por: Chan, Szeman Ruby, et al.
Publicado: (2012)

NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells
por: Erdős, Edina, et al.
Publicado: (2020)

pRb controls Estrogen Receptor alpha protein stability and activity
por: Caligiuri, Isabella, et al.
Publicado: (2013)

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
por: Allred, D Craig, et al.
Publicado: (2004)

Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer
por: Arendt, Lisa M, et al.
Publicado: (2011)

Estrogen regulates luminal progenitor cell differentiation through H19 gene expression
por: Basak, Pratima, et al.
Publicado: (2015)

Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers
por: Williams, Michelle M., et al.
Publicado: (2018)

Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer
por: Kumar, Sushil, et al.
Publicado: (2018)

AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner
por: Jian, Lei, et al.
Publicado: (2020)

Prenylflavonoid Icariin Induces Estrogen Response Element–Independent Estrogenic Responses in a Tissue-Selective Manner
por: Zhou, Liping, et al.
Publicado: (2019)

Intestinal TMEM16A control luminal chloride secretion in a NHERF1 dependent manner
por: Saha, Tultul, et al.
Publicado: (2021)

Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression
por: Chen, F, et al.
Publicado: (2014)

Genomic Profiling Shows Increased Glucose Metabolism in Luminal B Breast Cancer
por: Ueda, Shigeto, et al.
Publicado: (2013)

FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact
por: Metovic, Jasna, et al.
Publicado: (2022)

Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors
por: Lopez, Gianluca, et al.
Publicado: (2019)

Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis
por: Iannello, Andrea, et al.
Publicado: (2019)

Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes
por: Rondón-Lagos, Milena, et al.
Publicado: (2016)

ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer
por: Kalyuga, Maria, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kuoai36vr8idvb9no33gb0jhmk